| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Section of Immunobiology, Yale University School of Medicine, and
Howard Hughes Medical Institute, New Haven, CT 06520; and
Department of Microbiology and Immunology, University of Michigan School of Medicine, Ann Arbor, MI 48109
The NOD (nonobese diabetic) mouse is a good animal model for human IDDM. MHC class II-restricted CD4 T cells are necessary for the onset of diabetes in NOD mice. Here, we demonstrate that NOD mice lacking the CIITA (class II transactivator) molecule, and hence deficient in MHC class II expression and peripheral CD4 T cells, show significant pancreatic infiltration but do not develop diabetes. CD4 T cell deficiency, then, does not prevent initial pancreatic infiltration, but does stop progression to insulitis. Adoptive transfer studies show that the paucity of CD4 T cells in NOD-CIITA knockout mice is responsible for the absence of diabetes, since the CD8 T cell and B cell compartments are functional. An autoaggressive CD8+ T cell clone can, however, transfer diabetes in CIITA knockout recipient mice without CD4 T cell help, albeit with some delay compared with that in CIITA-sufficient recipients. This highlights the fact that a high number of in vitro activated autoaggressive CD8 T cells can over-ride the requirement for CD4 T cell help for the onset of diabetes.
This article has been cited by other articles:
|
|
 |
|
  N. Marzo, S. Ortega, T. Stratmann, A. Garcia, M. Rios, A. Gimenez, R. Gomis, and C. Mora Cyclin-Dependent Kinase 4 Hyperactivity Promotes Autoreactivity in the Immune System but Protects Pancreatic Cell Mass from Autoimmune Destruction in the Nonobese Diabetic Mouse Model J. Immunol., January 15, 2008; 180(2): 1189 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kim, H. S. Kim, K. W. Chung, S. H. Oh, J. W. Yun, S.-H. Im, M.-K. Lee, K.-W. Kim, and M.-S. Lee Essential Role for Signal Transducer and Activator of Transcription-1 in Pancreatic {beta}-Cell Death and Autoimmune Type 1 Diabetes of Nonobese Diabetic Mice Diabetes, October 1, 2007; 56(10): 2561 - 2568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Calderon, A. Suri, and E. R. Unanue In CD4+ T-Cell-Induced Diabetes, Macrophages Are the Final Effector Cells that Mediate Islet {beta}-Cell Killing: Studies from an Acute Model Am. J. Pathol., December 1, 2006; 169(6): 2137 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Chamberlain, M. Wallberg, D. Rainbow, K. Hunter, L. S. Wicker, and E. A. Green A 20-Mb Region of Chromosome 4 Controls TNF-{alpha}-Mediated CD8+ T Cell Aggression Toward beta Cells in Type 1 Diabetes J. Immunol., October 15, 2006; 177(8): 5105 - 5114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Smith, T. Patterson, and M. E. Pauza Transgenic Ly-49A Inhibits Antigen-Driven T Cell Activation and Delays Diabetes J. Immunol., April 1, 2005; 174(7): 3897 - 3905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Alba, M. C. Puertas, J. Carrillo, R. Planas, R. Ampudia, X. Pastor, F. Bosch, R. Pujol-Borrell, J. Verdaguer, and M. Vives-Pi IFN{beta} Accelerates Autoimmune Type 1 Diabetes in Nonobese Diabetic Mice and Breaks the Tolerance to {beta} Cells in Nondiabetes-Prone Mice J. Immunol., December 1, 2004; 173(11): 6667 - 6675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. McGregor, S. P. Schoenberger, and E. A. Green CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes PNAS, June 22, 2004; 101(25): 9345 - 9350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mora, I. S. Grewal, F. S. Wong, and R. A. Flavell Role of L-selectin in the development of autoimmune diabetes in non-obese diabetic mice Int. Immunol., February 1, 2004; 16(2): 257 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Eshima, C. Mora, F. S. Wong, E. A. Green, I. S. Grewal, and R. A. Flavell A crucial role of CD4 T cells as a functional source of CD154 in the initiation of insulin-dependent diabetes mellitus in the non-obese diabetic mouse Int. Immunol., March 1, 2003; 15(3): 351 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Rajagopalan, Y. C. Kudva, R. A. Flavell, and C. S. David Accelerated Diabetes in Rat Insulin Promoter-Tumor Necrosis Factor-{alpha} Transgenic Nonobese Diabetic Mice Lacking Major Histocompatibility Class II Molecules Diabetes, February 1, 2003; 52(2): 342 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Tompkins, J. Padilla, M. C. Dal Canto, J. P.-Y. Ting, L. Van Kaer, and S. D. Miller De Novo Central Nervous System Processing of Myelin Antigen Is Required for the Initiation of Experimental Autoimmune Encephalomyelitis J. Immunol., April 15, 2002; 168(8): 4173 - 4183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Harton and J. P.-Y. Ting Class II Transactivator: Mastering the Art of Major Histocompatibility Complex Expression Mol. Cell. Biol., September 1, 2000; 20(17): 6185 - 6194. [Full Text]
|
|
|
|
|
|
M. J. Cameron, G. A. Arreaza, M. Grattan, C. Meagher, S. Sharif, M. D. Burdick, R. M. Strieter, D. N. Cook, and T. L. Delovitch Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes J. Immunol., July 15, 2000; 165(2): 1102 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Green, F. S. Wong, K. Eshima, C. Mora, and R. A. Flavell Neonatal Tumor Necrosis Factor {alpha} Promotes Diabetes in Nonobese Diabetic Mice by Cd154-Independent Antigen Presentation to Cd8+ T Cells J. Exp. Med., January 17, 2000; 191(2): 225 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wen, F. S. Wong, J. Tang, N.-Y. Chen, M. Altieri, C. David, R. Flavell, and R. Sherwin In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (Hla)-Dq Molecules to the Development of Diabetes J. Exp. Med., January 3, 2000; 191(1): 97 - 104. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
